Parkwalk Advisors — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Charco Neurotech develops the CUE1, a non-invasive device that uses vibratory stimulation to ease movement symptoms and improve quality of life for people with Parkinson's disease.
Digital HealthHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersCambridge Angels groupNew Wave VenturesUTECCrista Galli Ventures
Hone Bio is a pre-clinical biotech company developing NanoPilot lipid nanoparticle (LNP) targeting technology for extrahepatic drug delivery, engineering LNPs to target specific cell types while blocking off-target liver uptake.
BiotechDeep TechBristol, GB
Co-investorsFuture Planet Capital
Mind Foundry develops deployed AI and machine learning systems for high-risk, high-complexity operational domains, including defense applications such as multi-sensor data fusion for battlespace situational awareness and threat-signature analysis.
AI & Machine LearningDeep TechDefense Tech
Stephen Roberts(Co-founder)inMichael Osborne(Co-founder)
Co-investorsOxford Science Enterprises
Novel antibody-based therapeutics platform for animal health.
Co-investorsCambridge Innovation CapitalCompanion FundDigitalis Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Oxford EndovascularTextMine
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.